Company profilePharmaceutical#95 of 1,318 in Pakistan1 DRAP alert

PACIFIC PHARMACEUTICALS LTD.

Pharmaceutical company · 172 brands · 167 molecules

Ranked #1 of 35 companies in Fever/Flu/Cough

172 registered products 79 pharmaceutical brands 167 distinct molecules 1 DRAP alert

Company overview

172
registered products
79
pharmaceutical brands
167
distinct molecules
11
therapeutic classes
1
DRAP alerts

PACIFIC PHARMACEUTICALS LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 172 product registrations across 167 distinct molecules. It is the 95th largest registrant in Pakistan by product count, and ranks 1st of 35 in Fever/Flu/Cough. Its portfolio is concentrated in Fever/Flu/Cough and Gastro. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by PACIFIC

109 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Angiotensin-Ii Antagonists, Combinations 2

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

66
ceilings with an approval date
66
not revised in 2+ years
2024
oldest approval year
202466
Longest without revision

Top molecules by brand count

Rifampicin20 brands
Isoniazid7 brands
Ibuprofen7 brands
Flavoxate5 brands
Vaginal5 brands
Ethambutol4 brands
Rifampicin ...... 150 Mg4 brands

Therapeutic classes

Fever/Flu/Cough · 8Gastro · 7Cardiac Care · 5Antiinflammatory And Antirheumatic Products · 4Antimycobacterials (Antituberculosis) · 4Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 3Drugs For Urinary Frequency And Incontinence · 3Anti-Infectives · 3Pain Management · 3Cough Suppressants And Expectorants, Combinations · 2Enzymes To Treat Inflammatory Condition · 2

Conditions treated

Cold/Cough/Sore Throat · 5Digestion · 4Tuberculosis · 3Fungal Infection · 3Ulcer/Reflux/Flatulence/Acidity · 2Cold/Dry Cough · 2Hypertension · 2Heart Failure · 2Pain Killers · 2Anxiety/Depression/Insomnia · 1Topical · 1Bladder & Prostate Disorder · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official110 products · Rs 10.76 – Rs 11,545.41
DVAGO17 products · Rs 90.4 – Rs 1,552.4
Servaid37 products · Rs 100.52 – Rs 1,629.6
Median across source: Rs 388.3

Regulatory record

1 alert in the DRAP feed we track.

Rapid Alert: CONTAMINATED PROPYLENE GLYCOL (BATCH # A803S96G46) PURPOTEDLY MANUFACTURED BY
2025-02-25

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Atco Pharma International (Pvt) Ltd holds 208 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline
SHAIGAN PHARMACEUTICALS (PVT) LTD. holds 114 molecules not in this portfolio
AlbendazoleAmikacinAmlodipineAmlodipine BasylateArtemetherAscorbic Acid
MACTER INTERNATIONAL (PVT) LTD. holds 156 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAminophylline

Get the full profile for PACIFIC

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.